Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

KITTEE TRC20 Token Ad

CARA Quote Trading Chart Cara Therapeutics Inc.


home / stock / cara / cara quote

$11.76 Last:

29.23% Change Percent:

$11.46 Open:

$9.10 Previous Close:

$11.85 High:

$11.4 Low:

64,945 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

CARA Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-08-1511.469.111.8511.464,945
2022-08-1211.729.111.811.31352,056
2022-08-1112.549.112.9811.55933,913
2022-08-1011.989.112.7811.68819,654
2022-08-0911.59.112.289911.48943,467
2022-08-0811.039.111.6510.9239615,043
2022-08-0510.399.111.3110.18652,398
2022-08-049.49.110.449.4572,978
2022-08-038.839.19.58.83406,156
2022-08-028.259.19.018.2456610,211
2022-08-018.869.18.868.13929,566
2022-07-2999.19.0358.66390,819
2022-07-289.19.19.198.87295,128
2022-07-269.129.129.3458.66204,822
2022-07-259.839.069.839.01287,959
2022-07-199.29.639.789.2460,608
2022-07-189.439.189.719.14394,430
2022-07-159.379.259.378.93323,368
2022-07-149.589.29.659.09316,986
2022-07-139.199.619.789.19266,129
Stock Information

Cara Therapeutics Inc. Company Name:

CARA Stock Symbol:

NASDAQ Market:

Cara Therapeutics Inc. Website:

CARA Quote Trading Chart Cara Therapeutics Inc.

MENU
CARA CARA Quote CARA Short CARA News CARA Articles CARA Message Board
Get CARA Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT CARA NEWS
  • CARA - Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Notalgia Paresthetica

    – Study achieved primary endpoint of Worst Itch-Numeric Rating Scale score change from baseline at Week 8 (p=0.001) – – Onset of action seen at Week 1 and sustained through Week 8 – – Statistical significance achieve...

  • CARA - Cara Therapeutics Reports First Quarter 2022 Financial Results

    KORSUVA™ (difelikefalin) injection U.S. commercial launch began in April 2022 and is tracking to expectation Kapruvia ® (difelikefalin) approved by European Commission for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...

  • CARA - Cara Therapeutics to Present at May Investor Conferences

    STAMFORD, Conn., May 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President an...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Discord

Join us on Discord

Follow us on discord to get immediate notifications!

Check out the New Market Wire News Discord Bot

Discord


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News